Back to top

Qiagen announces commercial launch of QIAsymphony Connect

Qiagen (QGEN) announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction. Bui...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

QIAGEN N.V. (QGEN)